Inspec

Inspec CapEx/D&A

The CapEx to Depreciation Ratio of Inspec (6656.T) as of Nov 13, 2026 is 7.23. In the previous year, CapEx to Depreciation Ratio was 6.54 — a change of 10.42% (higher).

CapEx/D&A

7.23

YoY

10.42%

Last updated:

CapEx to Depreciation Ratio of Inspec is 2025 7.23 . CapEx to Depreciation Ratio of Inspec was 2024 6.54 . It decreases by 10.42% higher compared to the previous year.

The Inspec CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2014
1.45 JPY
Jan 1, 2021
12.32 JPY
Jan 1, 2022
27.11 JPY
Jan 1, 2023
5.82 JPY
Jan 1, 2024
6.54 JPY
Jan 1, 2025
7.23 JPY
The Inspec CapEx/D&A history
YEARCapEx/D&AYoY
7.23+10.42%
6.54+12.51%
5.82-78.55%
27.11+120.05%
12.32+752.40%
1.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

CapEx to Depreciation Ratio of Inspec is 7.23 in 2025.

CapEx to Depreciation Ratio of Inspec changed from 6.54 to 7.23, representing a 10.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Inspec since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Inspec with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Inspec

All Key Metrics — Inspec